Stock Information
Agios Pharmaceuticals Inc (AGIO)
Ticker Symbol: AGIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,375.91 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -7.2504
Revenue (TTM): $1.12 M
Dividend Yield: N/A%
ROE: -34.11%
Latest News
-
10 Health Care Stocks With Whale Alerts In Today’s Session
Tue, Jul 21, 2026 1:35 PM
-
Agios Reports Neutral Sickle Cell Data, Decides To Stop Development
Tue, Jul 21, 2026 11:44 AM
-
HC Wainwright & Co. Maintains Buy on Agios Pharmaceuticals, Lowers Price Target to $52
Tue, Jul 21, 2026 11:31 AM
-
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Tue, Jul 21, 2026 8:01 AM
-
Agios Pharma Announces Topline Results From Phase 2 Trial Of Tebapivat, Oral Pyruvate Kinase Activator, In Patients Aged 16 Years Or Older With Sickle Cell Disease
Tue, Jul 21, 2026 7:04 AM
Key Financials
Financial data not available
